Revenue increased 7.5%
Revenue changed +7.5% from the comparable as-filed period.
$1.2B→$1.3B3 prior comparisons
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Revenue changed +7.5% from the comparable as-filed period.
Cash & equivalents changed -4.8% from the comparable as-filed period.
Selling, general & administrative changed +8.5% from the comparable as-filed period.
Inventory changed +2.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.